# EDGAR Filing Document

**Accession Number:** 0001275187
**File Stem:** 0000914121-23-000135
**Filing Date:** 2023-2
**Character Count:** 4597
**Document Hash:** e62e103d18c64c93149e6442cea2c989
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000914121-23-000135.hdr.sgml**: 20230227

**ACCESSION NUMBER**: 0000914121-23-000135

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20230227

**ITEM INFORMATION**: Other Events

**FILED AS OF DATE**: 20230227

**DATE AS OF CHANGE**: 20230227

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ANGIODYNAMICS INC
- **CENTRAL INDEX KEY:** 0001275187
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **IRS NUMBER:** 113146460
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0531

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-50761
- **FILM NUMBER:** 23671863

**BUSINESS ADDRESS:**
- **STREET 1:** 14 PLAZA DRIVE
- **CITY:** LATHAM
- **STATE:** NY
- **ZIP:** 12110
- **BUSINESS PHONE:** 5187981215

**MAIL ADDRESS:**
- **STREET 1:** 14 PLAZA DRIVE
- **CITY:** LATHAM
- **STATE:** NY
- **ZIP:** 12110

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### WASHINGTON, D.C. 20549

#### __________

### FORM 8-K

#### CURRENT REPORT

#### Pursuant to Section 13 or 15(d) of the

#### Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): **February 27, 2023**

### AngioDynamics, Inc.
(Exact Name of Registrant as Specified in Charter)

---

| | | |
|:---|:---|:---|
| **Delaware**<br>| **000-50761**<br>| **11-3146460** |
| (State or Other Jurisdiction of Incorporation) | (Commission File<br> Number) | (IRS Employer<br> Identification No.) |
| **14 Plaza Drive Latham, New York 12110** | **14 Plaza Drive Latham, New York 12110** | **14 Plaza Drive Latham, New York 12110** |
| (Address of Principal Executive Offices) (Zip Code) | (Address of Principal Executive Offices) (Zip Code) | (Address of Principal Executive Offices) (Zip Code) |
| (518) 795-1400 | (518) 795-1400 | (518) 795-1400 |
| (Registrant's telephone number, including area code) | (Registrant's telephone number, including area code) | (Registrant's telephone number, including area code) |

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))

#### Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| <u>Title of each class</u> | <u>Trading Symbol(s)</u> | <u>Name of each exchange on which<br> registered</u> |
| Common Stock, par value $0.01 per share<br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ANGO<br>| NASDAQ Global Select Market<br>|

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

#### Item 8.01 – Other Events.
On February 27, 2023, AngioDynamics, Inc. (the "Company") announced that Richard C. Rosenzweig has resigned from his positions as Senior Vice President, General Counsel and Secretary of the Company, effective February 27, 2023, to pursue another opportunity. James C. Clemmer, the Company's President and Chief Executive Officer, commented: "Rich was offered an opportunity to join Dentsply Sirona Inc. where he will work with a long-time colleague and we wish him the best."

------

#### SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | ANGIODYNAMICS, INC.<br>(Registrant) | ANGIODYNAMICS, INC.<br>(Registrant) |
| Date: February 27, 2023<br>| By:  | /s/ Stephen A. Trowbridge |
|  |  | Name: Stephen A. Trowbridge |
|  |  | Title:&nbsp;&nbsp;&nbsp;&nbsp; Executive Vice President and |
|  |  | Chief Financial Officer <br>|

---

------